학술논문

Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention
Document Type
Article
Source
In Journal of Stroke and Cerebrovascular Diseases October 2022 31(10)
Subject
Language
ISSN
1052-3057